Connor, Clark & Lunn Investment Management (CC&L)’s Tectonic Therapeutic TECX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.23M	Sell	64,940 -2,054	-3%	-$60.3K	﹤0.01%	975
2026 Q1	$2.07M	Sell	66,994 -4,663	-7%	-$115K	﹤0.01%	948
2025 Q4	$1.49M	Buy	71,657 +27,772	+63%	+$516K	﹤0.01%	1008
2025 Q3	$689K	Buy	43,885 +8,177	+23%	+$169K	﹤0.01%	1174
2025 Q2	$710K	Buy	35,708 +1,063	+3%	+$21.6K	﹤0.01%	1148
2025 Q1	$614K	Buy	34,645 +20,160	+139%	+$657K	﹤0.01%	1091
2024 Q4	$669K	Buy	14,485 +6,783	+88%	+$287K	﹤0.01%	1062
2024 Q3	$233K	Buy	+7,702	New	+$141K	﹤0.01%	1297
2022 Q2	–	Sell	-12,563	Closed	-$199K	–	1223
2022 Q1	$199K	Buy	12,563 +2,578	+26%	+$53.3K	﹤0.01%	946
2021 Q4	$461K	Buy	9,985 +4,413	+79%	+$254K	﹤0.01%	813
2021 Q3	$373K	Buy	+5,572	New	+$457K	﹤0.01%	830

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s TECX Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) reduced its Tectonic Therapeutic (TECX) stake by 3.1% in Q2 2026, selling an estimated $60.3K and leaving 64,940 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #975.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in TECX in Q3 2021 and has held it in 11 quarters since. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

Connor, Clark & Lunn Investment Management (CC&L) held 64,940 shares of Tectonic Therapeutic worth $2.23M as of Q2 2026.
Connor, Clark & Lunn Investment Management (CC&L) sold 2,054 Tectonic Therapeutic shares in Q2 2026, an estimated $60.3K.
Tectonic Therapeutic made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #975 holding.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Tectonic Therapeutic in Q3 2021 and has held it in 11 quarters since.
123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.